Bank of New York Mellon Corp
BankPosition in ENTA — Enanta Pharmaceuticals Inc
CIK 1390777
NEW YORK, NY
Position in ENTA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,119,101
+$225,114 QoQ
Shares Held
76,756
+8.4% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. ENTA ranks #188 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ENTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,119,101 | 76,756 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $893,987 | 70,783 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,144,711 | 72,588 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $724,099 | 60,493 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $419,382 | 55,474 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $293,928 | 53,248 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $328,438 | 57,120 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $602,193 | 58,127 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $957,715 | 73,841 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,138,319 | 65,196 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $683,410 | 72,626 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,205,856 | 107,955 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,547,968 | 165,793 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $6,781,907 | 167,703 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $7,834,851 | 168,419 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,034,662 | 174,179 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,931,667 | 167,795 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $13,004,654 | 182,701 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $14,616,570 | 195,461 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $10,415,656 | 183,342 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $7,762,172 | 176,373 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $9,586,917 | 194,382 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,129,255 | 193,094 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $9,004,145 | 196,683 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,608,786 | 191,372 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $9,502,976 | 184,775 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||